OBJECTIVE: The objective of the study was to investigate whether knowledge of human
papillomavirus (HPV) deoxyribonucleic acid test results increases sensitivity of guided …

OBJECTIVE: Testing for human papillomavirus (HPV) has been shown to increase the
sensitivity and negative predictive value for detection of high-grade cervical intraepithelial …

We conducted a prospective randomized controlled trial with two screening rounds to
evaluate the effectiveness of combining HPV testing with liquid‐based cytology (LBC) as a …

Human papillomavirus (HPV) testing is used in primary cervical screening, as an adjunct to
cervical cytology for the management of low grade abnormal cytology, and in a test of cure …

Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

We conducted studies in Vanuatu to evaluate potential screening and treatment strategies to
assist with control of cervical cancer. In a pilot study of 496 women, visual inspection and …

High-risk human papillomavirus (HPV) DNA/RNA testing provides higher sensitivity but
lower specificity than cytology for the identification of high-grade cervical intraepithelial …

OBJECTIVE.: Human papilloma virus (HPV) testing and repeat cytology are both proposed
as methods to triage women with minor cytological cervical lesions. By triage, those women …

Several studies have shown that HPV testing is substantially more sensitive than cytology for
primary cervical screening. However, less data exist concerning the duration of protection …

Objective To establish the prevalence of high‐grade cervical intraepithelial neoplasia
(CIN2+) in women referred to colposcopy with persistent high‐risk human papillomavirus …